Select Publications
Conference Presentations
, 2021, 'Perceptions and concerns of hepatitis c reinfection in the prison setting', presented at Justice Health Conference, Public Health Association Australia, Virtual (Australia), 03 November 2021 - 04 November 2021
, 2021, 'Correctional Officers and Health Staff Perspectives Of Hepatitis C Treatment As Prevention Scale Up Within The Prison Setting', presented at International Conference on Health and Hepatitis in Substance Users (INHSU), Virtual (International), 13 October 2021 - 15 October 2021
, 2021, 'Scaling Up Hepatitis C Treatment within the Prison Setting: The Role of Social Capital', presented at Academic and Health Policy Conference on Correctional Health (ACCJH), Virtual (USA), 08 April 2021 - 10 April 2021
, 2021, 'Optimised approach for high throughput hepatitis C virus amplification for transmission cluster identification in Australian prisons', presented at 16th National Scientific Workshop of the Australian Center for HIV and Hepatitis Virology Research, Bowral, Australia
, 2020, 'Resolving within-host, full length, dengue virus variants without haplotype reconstruction using Oxford Nanopore Technology', presented at ECCMID 2020, Paris, France
, 2019, 'A single nested PCR method for full length dengue virus genome amplification', presented at 7th European Congress of Virology, Rotterdam, The Netherlands
, 2019, 'Using networks to study epistatic interactions of HCV', presented at 14th Scientific Workship of the Australian Center for HIV and Hepatitis Virology Research, Canungra, Australia
, 2019, 'Whole genome long read sequencing of Hepatitis C virus and its applications', presented at 14th National Scientific Workshop of the Australian Center for HIV and Hepatitis Virology Research, Canungra, Australia
, 2018, 'Challenges in characterizing hepatitis C virus founder variants with deep sequencing', presented at 13th National Scientific Workshop of the Australian Center for HIV and Hepatitis Virology Research
, 2018, 'Genetic variability of Hepatitis C quasi-species in early infection', presented at Global Hepatitis Summit, Toronto, Canada
, 2018, 'Host IFNλ3 genotype and viral genotype are key determinants of within-host HCV genomic variation in early infection', presented at 13th National Scientific Workshop of the Australian Center for HIV and Hepatitis Virology Research, Yarra Valley, Australia
, 2017, 'A framework for hepatitis C virus treatment as prevention in the prison setting: the SToP-C implementation toolkit', presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, NETHERLANDS, Amsterdam, 19 April 2017 - 23 April 2017, http://dx.doi.org/10.1016/S0168-8278(17)31387-9
, 2017, 'Establishment of InC3 viral sequence repository and its applications', presented at 12th National Scientific Workshop of the Australian Center for HIV and Hepatitis Virology Research, Barossa Valley, Australia
, 2016, 'Bayesian evolutionary analysis of hepatitis C epidemic in Australia and North America in 20th century', presented at Australasian Viral Hepatitis Conference, GoldCoast, Australia
, 2016, 'Bayesian evolutionary analysis of hepatitis C epidemic in Australia and North America in 20th century', presented at International conference in Systems Biology, Barcelona, Spain
, 2016, 'Broadly neutralizing antibodies against hepatitis C envelope; using a network approach to understand co-evolution of critical residues', presented at International conference in Systems Biology, Barcelona, Spain
, 2016, 'Examining past and future hepatitis C virus epidemic trends in the era of directly acting antivirals', presented at Australian Society of Microbiology annual scientific meeting, Perth, Australia
, 2016, 'Molecular epidemiology of full length hepatitis C virus genomes among injecting drug users with recent infection: The InC3 study', presented at 5th International Symposium on Hepatitis Care in Substance Users, Oslo, Norway
, 2016, 'Trends of Hepatitis C virus infections in North America and Australia in 20th century; back projections from molecular epidemiology', presented at 5th International Symposium on Hepatitis Care in Substance Users, Oslo, Norway
, 2015, 'A network approach for the identification of co-evolving mutations in Hepatitis C Virus (HCV) in the context of immune escape against neutralizing antibody responses', presented at COMBINE Student Symposium, Sydney, Australia
, 2015, 'Characterizing neutralizing antibody responses targeting founder virus in early primary HCV infection with varying disease outcome', presented at International Symposium on Hepatitis C virus and related viruses, Strasbourg, France
, 2015, 'Global molecular epidemiology of acute hepatitis infection via phylogenetic analysis of full length genomes across nine international cohorts', presented at 11th National Scientific Workshop of the Australian Center for HIV and Hepatitis Virology Research, Hunter Valley, Australia
, 2015, 'Identification of co-evolving mutations of the Hepatitis C virus in the context of immune escape against neutralizing antibody responses using a bioinformatics workflow', presented at 8th Australasian virology society meeting, Hunter Valley, Australia
, 2015, 'Natural prevalence of HCV resistance associated variants in treatment naïve patients across six genotypes', presented at 11th National Scientific Workshop of the Australian Center for HIV and Hepatitis Virology Research, Hunter Valley, Australia
, 2015, 'Understanding the timing, breadth and potency of neutralising antibody responses against transmitted/founders', presented at 11th National Scientific Workshop of the Australian Center for HIV and Hepatitis Virology Research, Hunter Valley, Australia
Conference Abstracts
, 2022, 'Hepatitis C virus reinfection following direct acting antiviral treatment in the prison setting: the SToP-C study', in Journal of Hepatology, Elsevier BV, Vol. 77, pp. S565 - S565, http://dx.doi.org/10.1016/s0168-8278(22)01451-9
, 2021, 'BASELINE PREDICTORS OF POST-PARTUM HEPATITIS B E ANTIGEN SEROCONVERSION', in HEPATOLOGY, WILEY, Vol. 74, pp. 446A - 447A, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000707188002141&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2020, 'B cell immunodominance in primary hepatitis C virus infection', in JOURNAL OF HEPATOLOGY, ELSEVIER, Vol. 72, pp. E38 - E38, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000520050900030&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2019, 'GENOTYPE MISCLASSIFICATION NEGATIVELY IMPACT THE CHOICE OF REGIMENS AND TREATMENT OUTCOMES IN THE MANAGEMENT OF HEPATITIS C', in HEPATOLOGY, WILEY, MA, Boston, Vol. 70, pp. 318A - 319A, presented at Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, MA, Boston, 08 November 2019 - 12 November 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000488653501070&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2019, 'HCV RESISTANCE PATTERNS IN A WORLDWIDE NETWORK OF COHORTS OF GT-3a INFECTED PATIENTS', in HEPATOLOGY, WILEY, MA, Boston, Vol. 70, pp. 180A - 181A, presented at Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, MA, Boston, 08 November 2019 - 12 November 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000488653500277&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2019, 'THE GLOBAL PREVALENCE OF RESISTANCE ASSOCIATED SUBSTITUTIONS (RASS) IN "UNUSUAL" HCV SUBTYPES', in HEPATOLOGY, WILEY, MA, Boston, Vol. 70, pp. 77A - 78A, presented at Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, MA, Boston, 08 November 2019 - 12 November 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000488653500117&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2019, 'Reduction in Peripheral C-Reactive Protein Levels With Canakinumab Administration is Related to Reduced Positive Symptom Severity in Patients With Schizophrenia and Inflammation', in BIOLOGICAL PSYCHIATRY, ELSEVIER SCIENCE INC, IL, Chicago, Vol. 85, pp. S44 - S45, presented at 74th Annual Meeting of the Society-of-Biological-Psychiatry (SOBP), IL, Chicago, 16 May 2019 - 18 May 2019, http://dx.doi.org/10.1016/j.biopsych.2019.03.121
, 2019, 'REDUCTION IN PERIPHERAL C-REACTIVE PROTEIN LEVELS WITH CANAKINUMAB ADMINISTRATION IS RELATED TO REDUCED POSITIVE SYMPTOM SEVERITY IN PATIENTS WITH SCHIZOPHRENIA AND INFLAMMATION', in SCHIZOPHRENIA BULLETIN, OXFORD UNIV PRESS, FL, Orlando, Vol. 45, pp. S318 - S318, presented at Congress of the Schizophrenia-International-Research-Society (SRIS), FL, Orlando, 10 April 2019 - 14 April 2019, http://dx.doi.org/10.1093/schbul/sbz020.578
, 2017, 'Systematic review & expert guidance on methods for sequencing of hepatitis C virus for detection of direct-acting antiviral resistance', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, NETHERLANDS, Amsterdam, Vol. 66, pp. S323 - S323, presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, NETHERLANDS, Amsterdam, 19 April 2017 - 23 April 2017, http://dx.doi.org/10.1016/S0168-8278(17)30970-4
, 2001, 'Amelioration of TNBS colitis in mice using prebiotics', in GASTROENTEROLOGY, W B SAUNDERS CO, Vol. 120, pp. A82 - A82
, 2000, 'Chemokine receptor expression and function in lamina propria mononuclear cells of the human colon.', in GASTROENTEROLOGY, W B SAUNDERS CO, Vol. 118, pp. A355 - A355, http://dx.doi.org/10.1016/S0016-5085(00)83524-6
Preprints
, 2025, Between- and within-host mutation of dengue virus, http://dx.doi.org/10.1101/2025.10.12.680595
, 2025, Early circulating biomarker signatures of dengue-associated plasma leakage uncovered by proteomics, http://dx.doi.org/10.1101/2025.07.03.25330389
, 2025, Highly replicating hepatitis C virus variants emerge in immunosuppressed patients causing severe disease., http://dx.doi.org/10.21203/rs.3.rs-6194507/v1
, 2025, Chikungunya masquerading as dengue infection in Sri Lanka uncovered by metagenomics, http://dx.doi.org/10.1101/2025.05.30.25328620
, 2024, Temporal dynamics of viral fitness and the adaptive immune response in HCV infection, http://dx.doi.org/10.1101/2024.09.07.611784
, 2023, Characterisation of antibody dependent cellular phagocytosis in patients infected with Hepatitis C virus with different clinical outcomes, http://dx.doi.org/10.22541/au.168992839.95818489/v1
, 2023, A unique cytotoxic CD4+T cells signature defines critical COVID-19, http://dx.doi.org/10.1101/2023.02.17.23286059
, 2023, Preparing correctional settings for the next pandemic: a modelling study of COVID-19 outbreaks in two high-income countries, http://dx.doi.org/10.1101/2023.05.08.23289690
, 2022, Prevalence and predictors of long COVID among non-hospitalised adolescents and young adults: a prospective controlled cohort study, http://dx.doi.org/10.21203/rs.3.rs-2021203/v1
, 2021, Single cell multi-omics reveals early elevated function and multiple fates within human progenitor exhausted CD8+ T cells, http://dx.doi.org/10.1101/2021.09.09.459584
, 2021, The COVID-19 Incarceration Model: a tool for corrections staff to analyze outbreaks of COVID-19, http://dx.doi.org/10.1101/2021.02.18.21252032
, 2020, Long-term persistence of neutralizing memory B cells in SARS-CoV-2, http://dx.doi.org/10.21203/rs.3.rs-92527/v1
, 2017, B-cell receptor reconstruction from single-cell RNA-seq with VDJPuzzle, http://dx.doi.org/10.1101/181156
, 2017, Impact of sequencing depth and read length on single cell RNA sequencing data: lessons from T cells, http://dx.doi.org/10.1101/134130